Journal
BIOCHEMISTRY
Volume 48, Issue 51, Pages 12233-12241Publisher
AMER CHEMICAL SOC
DOI: 10.1021/bi901181z
Keywords
-
Categories
Funding
- National Institutes of Health Research [CA89450, ES07028]
- National Institutes of Health/National Institute of Drug Abuse [DA02014]
- Vanderbilt Institute of Chemical Biology
Ask authors/readers for more resources
N-(4-Hydroxyphenyl)arachidonoylamide (AM404) is an inhibitor of endocannabinoid inactivation that has been used in cellular and animal studies. AM404 is a derivative of arachidonic acid and has been reported to inhibit arachidonate oxygenation by prostaglandin endoperoxide synthase-1 and -2 (PGHS-1 and -2, respectively). While examining the structural requirements for inhibition of PGHS, we discovered that the meta isomer of AM404, N-(3-hydroxyphenyl)arachidonoylamide (3-HPAA), is a substrate for purified PGHS. PGHS-2 efficiently oxygenated 3-HPAA to prostaglandin and hydroxyeicosatetraenoate products. No oxidation of the phenolamide moiety was observed. 3-HPAA appeared to be converted by PGHS-1 in a similar manner; however, conversion was less efficient than that by PGHS-2. PGHS-2 was selectively, dose-dependently, and irreversibly inactivated in the presence of 3-HPAA. Complete Inactivation of PGHS-2 was achieved with 10 mu M 3-HPAA. Preliminary characterization revealed that 3-HPAA inactivation did not result from covalent modification of PGHS-2 or damage to the heme moiety. These Studies provide additional insight into the structural requirements for Substrate metabolism and inactivation of PGHS and report the first metabolism-dependent, selective inactivator of PGHS-2.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available